Maravai Lifesciences Holdings (MRVI) Capital Leases (2020 - 2026)

Maravai Lifesciences Holdings' Capital Leases history runs 6 years deep, the most recent figure standing at $29.9 million for Q1 2026.

• In Q1 2026, Capital Leases fell 3.28% year-over-year to $29.9 million; the TTM figure through Mar 2026 stood at $29.9 million (down 3.28% YoY), while the FY2025 annual figure was $30.1 million, down 3.1% from the prior year.
• Capital Leases was $29.9 million for Q1 2026 at Maravai Lifesciences Holdings, down from $30.1 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $32.2 million in Q2 2023 to a low of $16.6 million in Q1 2023.
• Historically, Capital Leases has averaged $30.0 million across 4 years, with a median of $31.1 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Capital Leases surged 91.41% in 2024, then retreated 3.28% in 2026.
• A 4-year view of Capital Leases shows it stood at $31.9 million in 2023, then decreased by 2.48% to $31.1 million in 2024, then fell by 3.1% to $30.1 million in 2025, then dropped by 0.9% to $29.9 million in 2026.
• The last three Capital Leases figures came in at $29.9 million (Q1 2026), $30.1 million (Q4 2025), and $30.4 million (Q3 2025), per Business Quant data.